I am not suggesting to risk money you can't afford to lose but as with most small bio plays, there is always a lot of risk (no matter what the stock price may be at). You just have to hope your DD has helped you find one with a good risk/reward. Remember, it was not too long ago that ACAD was trading in the low single digits. Hell, look at stocks like CLDX, PCYC, MDVN etcv all a few years ag were trading at much, much lower levels. As for BLRX, based on their market cap and pipeline, i like the risk/reward. Couple that with NVS recent investment I am even more confident there is something there. We shall see.
Long acad too
and let's not forge they are buying shares above current market levels. this is very big because normally a huge company like nvs would buy shares at or below current market levels. obviously they like what they see
It's hard to really believe you own shares. It appears more that you are short. Todays news is positive.
I think the deal is pretty good. BLRX is working with an absolute giant, Novartis. For a company this small, this is huge. It not only brings much needed capital to the company but it gives their pipeline credibility and let's face it, if their pipeline has potential, Novartis will certainly help to develop it. All too often these small bios bumble and stumble because they lack true leadership and experience. With Novartis on board, i feel much more confident.
Huge deal for tiny BLRX
nice to see all of the recruiting
we will see
Disagree. Company is planning to list on the nasdaq before the end of the year. Needed to do a reverse split to meet the qualifications. Stock is ridiculously undervalued. Based on potential alone should be $40+ given the float. Listing on the nasdaq will give them more exposure. If they can announce news (maybe a partnership), this will go parabolic
Should be $5-$8+ right now based on recent results
Radar BLRX and CYNAF
Big presentation coming on December 12th.
It's on their website under news/events
December 6, 2014
BioLineRx to present at the 56th ASH Annual Meeting and Exposition December 6 - 9, 2014 in San Francisco, CA
San Francisco, CA
Poster Title: BL-8040, a peptidic CXCR4 antagonist, induces Leukemia cell death and specific Leukemia cell mobilization in Relapsed/Refractory Acute Myeloid Leukemia patients in an ongoing phase IIa clinical trial
Date: Saturday, December 6, 2014
Presentation Time: 5:30 PM PST - 7:30 PM PST
i'm in CYNAF too.I really like that one. ACAD is my biggest holding, then SRPT but I have built a big position in CYNAF, SCTPF and recently BLRX. CYNAF should be much higher imo
BL-8040, a peptidic CXCR4 antagonist, induces Leukemia cell death and specific Leukemia cell mobilization in Relapsed/Refractory Acute Myeloid Leukemia patients in an ongoing phase IIa clinical trial